Skip to content
10-Q

Quarterly Report

NEURAXIS, INC. NRXS

0001641172-25-009571

← back to feed
Filed
May 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Mar 31, 2025 7.22M sh
Short Term Debt Q1 2025 · Mar 31, 2025 $84.31K
Cash And Equivalents Q1 2025 · Mar 31, 2025 $2.01M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $3.7M
Current Liabilities Q1 2025 · Mar 31, 2025 $2.1M
Current Liabilities Q1 2025 · Dec 31, 2024 $2.43M
Total Liabilities Q1 2025 · Mar 31, 2025 $2.77M
Total Liabilities Q1 2025 · Dec 31, 2024 $2.69M
Current Assets Q1 2025 · Mar 31, 2025 $2.54M
Current Assets Q1 2025 · Dec 31, 2024 $4.27M
Total Assets Q1 2025 · Mar 31, 2025 $3.03M
Total Assets Q1 2025 · Dec 31, 2024 $4.76M
Shares Diluted Q1 2025 · Mar 31, 2024 6.55M sh
Capex Q1 2025 · Mar 31, 2024 $14.72K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$1.33M
Stockholders Equity Q1 2025 · Mar 31, 2024 −$3.18M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$1.4M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.32
Eps Basic Q1 2025 · Mar 31, 2024 −$0.32
Sga Expense Q1 2025 · Mar 31, 2024 $2.32M
Rd Expense Q1 2025 · Mar 31, 2024 $5.57K
Net Income Q1 2025 · Mar 31, 2024 −$2.12M
Operating Income Q1 2025 · Mar 31, 2024 −$1.83M
Gross Profit Q1 2025 · Mar 31, 2024 $571.55K
Cost Of Revenue Q1 2025 · Mar 31, 2024 $75.08K
Revenue Q1 2025 · Mar 31, 2024 $646.64K